Coronary Artery Aneurysm: Complete ICD-11 Coding Guide (BA81)

1. Introduction

Coronary artery aneurysm represents a relatively uncommon but clinically significant vascular condition, characterized by abnormal dilation of coronary vessels. This pathology deserves special attention both for its diagnostic complexity and for the potential serious cardiovascular complications it can trigger. Unlike coronary stenoses, which are widely known and studied, coronary aneurysms present unique challenges for cardiologists and vascular disease specialists.

The prevalence of this condition has been increasingly recognized with advances in cardiovascular imaging techniques, particularly with the widespread use of coronary angiography and cardiac computed tomography. Although considered a relatively rare condition, its identification has increased significantly in recent decades, not necessarily due to increased incidence, but mainly due to improvements in available diagnostic methods.

From a public health perspective, coronary artery aneurysm represents an important challenge. Patients with this condition present increased risk of adverse cardiovascular events, including coronary thrombosis, aneurysmal rupture, distal embolization, and compression of adjacent cardiac structures. Appropriate management of these patients requires continuous surveillance and, in many cases, specific therapeutic interventions.

Correct coding of this condition in the ICD-11 system is absolutely critical for several reasons. First, it enables appropriate epidemiological tracking of this pathology, facilitating prevalence and incidence studies in different populations. Second, it ensures appropriate reimbursement by health services, considering that management of these patients frequently involves high-complexity diagnostic and therapeutic procedures. Third, it facilitates communication among health professionals, ensuring continuity of care and appropriate follow-up. Finally, it contributes to clinical research and the development of evidence-based therapeutic protocols.

2. Correct ICD-11 Code

The specific code for coronary artery aneurysm in the International Classification of Diseases, 11th Revision, is BA81. This code is inserted in the chapter on diseases of the circulatory system, more specifically within the grouping of coronary artery diseases.

The official definition established by the World Health Organization for this condition is precise and measurable: it is a coronary dilation that exceeds the diameter of adjacent normal segments or the diameter of the patient's largest coronary vessel by 1.5 times. This quantitative criterion is fundamental for standardizing diagnosis and avoiding confusion with mild coronary ectasias or normal anatomical variations.

The parent category of this classification corresponds to coronary artery diseases, a grouping that encompasses various pathologies affecting the vessels responsible for irrigating the cardiac muscle. This hierarchical location in the coding system reflects the nature of the condition as a primary structural alteration of the coronary vessels.

It is important to emphasize that code BA81 refers specifically to acquired coronary artery aneurysms. This distinction is crucial, as aneurysms of congenital origin have different coding and distinct clinical implications. The acquired nature of this condition is usually associated with atherosclerotic, inflammatory, infectious, or iatrogenic processes, differentiating itself from vascular malformations present since birth.

The ICD-11 system offers greater specificity compared to the previous version, allowing more precise documentation of the characteristics of this condition. The definition based on measurable criteria (dilation greater than 1.5 times the normal diameter) facilitates consistent application of the code by different professionals in various clinical contexts.

3. When to Use This Code

The code BA81 should be used in specific clinical situations where there is diagnostic confirmation of acquired coronary aneurysm. Below, we present detailed practical scenarios:

Scenario 1: Incidental discovery during cardiac catheterization A 58-year-old patient undergoes coronary angiography for investigation of stable angina. During the procedure, focal dilation of the right coronary artery measuring 8mm is identified, while adjacent segments measure 4mm. The 2:1 ratio characterizes coronary aneurysm according to diagnostic criteria. In this case, code BA81 is appropriate, even though the aneurysm is not the primary indication for the procedure.

Scenario 2: Patient with history of Kawasaki disease in childhood A 35-year-old adult with documented history of mucocutaneous lymph node syndrome (Kawasaki disease) in childhood presents for routine cardiological evaluation. Coronary angiography computed tomography reveals a 12mm saccular aneurysm in the left anterior descending artery. Although the etiology is related to prior Kawasaki disease, the aneurysm itself is coded as BA81, and a complementary code for Kawasaki disease history may be added.

Scenario 3: Complication post-percutaneous coronary intervention A patient who underwent angioplasty with stent implantation develops, after six months, aneurysmal dilation in the treated segment, confirmed by angiography. The vessel shows dilation of 9mm compared to 4mm in adjacent segments. This iatrogenic aneurysm should be coded as BA81, with possible additional code for procedure complication.

Scenario 4: Aneurysm associated with atherosclerosis A 67-year-old patient with diffuse coronary atherosclerotic disease presents with a fusiform aneurysm of the circumflex artery, measuring 10mm in a segment with 5mm normal diameter. Computed tomography confirms atherosclerotic calcification in the aneurysm walls. Code BA81 is appropriate, and may be complemented with codes for coronary atherosclerotic disease.

Scenario 5: Multiple aneurysms in coronary arteries A patient presents with aneurysms in two distinct coronary territories: one in the left anterior descending artery (7mm versus 3.5mm normal) and another in the right coronary artery (9mm versus 4mm normal). Both meet diagnostic criteria for dilation greater than 1.5 times. Code BA81 is applied, with documentation of aneurysm multiplicity.

Scenario 6: Symptomatic giant aneurysm A patient with a giant coronary aneurysm (greater than 20mm) of the right coronary artery presents with symptoms of cardiac chamber compression and thrombosis risk. Echocardiography and magnetic resonance imaging confirm the diagnosis. Code BA81 is appropriate, with additional specification of dimensions and complications when available in the electronic health record system.

4. When NOT to Use This Code

Accuracy in coding requires clear knowledge of situations where code BA81 should not be applied. The main exclusions include:

Congenital coronary artery aneurysm: When there is evidence that coronary dilation is present since birth or results from congenital vascular malformation, the appropriate code is the specific one for congenital anomalies of the cardiovascular system. This distinction is fundamental because the prognostic implications, clinical management, and follow-up differ significantly between congenital and acquired aneurysms. Congenital aneurysms are frequently associated with other cardiovascular anomalies and may have different clinical presentation.

Active mucocutaneous lymph node syndrome: During the acute phase of Kawasaki disease, when there is active vasculitis and aneurysm formation as part of the systemic inflammatory process, the primary code should reflect the active mucocutaneous syndrome. The coronary aneurysm, in this context, is a manifestation of the underlying disease, not an isolated entity. Only after resolution of the acute phase can residual aneurysms be coded as BA81.

Diffuse coronary ectasia: When there is coronary dilation that does not meet the criterion of 1.5 times the normal diameter, it is ectasia and not aneurysm. This quantitative distinction is important, as mild ectasias may represent anatomical variations or clinically less significant alterations. Precise documentation of vascular measurements is essential for this differentiation.

Coronary pseudoaneurysm: Unlike true aneurysms, which involve all layers of the arterial wall, pseudoaneurysms result from contained rupture of the vascular wall with encapsulated hematoma. This condition has a specific code and requires a different therapeutic approach, usually more urgent due to the risk of rupture.

Post-stenotic dilation: In some cases, there may be dilation of the coronary vessel immediately after significant stenosis, resulting from hemodynamic alterations. This post-stenotic dilation does not constitute a true aneurysm and should be coded as part of coronary atherosclerotic disease, not as BA81.

5. Step-by-Step Coding Process

Step 1: Assess diagnostic criteria

The first fundamental step is to confirm that the diagnosis of coronary artery aneurysm is properly established. This requires documentation of appropriate imaging examination, with coronary angiography being the gold standard. However, coronary computed tomography angiography and cardiac magnetic resonance imaging can also provide adequate diagnostic information.

Diagnostic confirmation should include precise measurements of the dilated segment diameter and comparison with adjacent normal segments or with the patient's largest coronary vessel. The ratio should be equal to or greater than 1.5:1 to characterize an aneurysm. Photographic or imaging documentation with annotated measurements is highly recommended.

It is also important to assess morphological characteristics of the aneurysm: whether it is saccular (focal and circumscribed dilation) or fusiform (elongated and symmetric dilation), whether there are intraluminal thrombi, parietal calcifications, or signs of contained rupture. This information, although not changing the primary code, is relevant for clinical management.

Step 2: Verify specifiers

After confirming the diagnosis, specific characteristics that may influence prognosis and treatment should be documented. The precise anatomical location of the aneurysm is fundamental: right coronary artery, left anterior descending, circumflex, or secondary branches. Aneurysms in different territories may have distinct implications.

The dimensions of the aneurysm should be recorded with precision. Giant aneurysms (generally defined as greater than 20mm) have higher risk of complications and may require more aggressive therapeutic approach. The presence of multiple aneurysms should also be documented.

Assessing the presence of associated complications is crucial: intraluminal thrombosis, distal embolization, compression of adjacent structures, rupture, or fistula. Each of these complications may require additional codes and certainly influences therapeutic decisions.

Step 3: Differentiate from other codes

BA82 - Coronary artery dissection: The main difference is that in dissection there is separation of the layers of the arterial wall with formation of a false lumen, whereas in aneurysm there is dilation with maintenance of the integrity (although pathological) of the vascular wall. Dissections typically present with acute chest pain and can cause acute myocardial ischemia, while aneurysms are often asymptomatic or cause chronic symptoms.

BA83 - Acquired coronary artery fistula: Fistulas represent abnormal communications between coronary artery and cardiac chambers or other vascular structures. Although aneurysms may eventually rupture and create fistulas, the two conditions are distinct. Fistulas are characterized by continuous abnormal flow between compartments that normally do not communicate, whereas aneurysms are focal dilations without abnormal communication.

BA84 - Chronic total occlusion of coronary artery: This condition represents complete and prolonged obstruction of coronary flow, the opposite of aneurysmal dilation. Although aneurysms may eventually thrombose and lead to occlusion, the presence of patent aneurysm should be coded as BA81. If complete occlusion of a previous aneurysm is documented, coding requires careful analysis of the clinical context.

Step 4: Required documentation

Adequate documentation should include:

Imaging examination report with detailed description of the aneurysm, including precise anatomical location, dimensions in millimeters, morphology (saccular or fusiform), and relationship with adjacent segments
Objective measurements demonstrating that the diameter of the dilated segment exceeds by 1.5 times or more the reference diameter
Complication assessment: presence or absence of thrombi, calcifications, signs of rupture or compression
Clinical context: related symptoms, history of previous coronary procedures, associated systemic diseases
Probable etiology: atherosclerosis, post-inflammatory, iatrogenic, idiopathic
Therapeutic plan: clinical observation, anticoagulation, surgical or percutaneous intervention

This complete documentation not only justifies BA81 coding but also facilitates longitudinal patient follow-up and communication among different professionals involved in care.

6. Complete Practical Example

Clinical Case

A 62-year-old male patient with a history of arterial hypertension and dyslipidemia under treatment for 10 years presents to the cardiologist for evaluation of intermittent atypical chest pain over the last three months. The pain does not have typical characteristics of angina, occurring at rest and without clear relationship to physical exertion. There are no symptoms of heart failure or other cardiovascular complaints.

On physical examination, the patient is in good general condition, blood pressure 138/82 mmHg, heart rate 72 bpm regular. Cardiac and pulmonary auscultation without abnormalities. No murmurs or abnormal sounds.

Resting electrocardiogram shows sinus rhythm, without ischemic or repolarization changes. Stress test is performed, achieving 9 METS without symptoms or electrocardiographic changes suggestive of ischemia.

Considering the persistence of symptoms and cardiovascular risk factors, computed tomography angiography of the coronaries is requested. The examination reveals:

Dominant right coronary artery with fusiform aneurysmal dilatation in the middle third, measuring 9mm in diameter, while proximal and distal segments measure 4mm (ratio 2.25:1)
Mild atherosclerotic calcifications on the aneurysm walls
Left anterior descending artery with non-obstructive atherosclerosis
Circumflex artery without significant changes
Absence of intraluminal thrombi or signs of rupture
Preserved ventricular function

Step-by-Step Coding

Analysis of diagnostic criteria: The patient presents with coronary dilatation documented by adequate imaging method (computed tomography angiography). The ratio between the dilated segment (9mm) and normal segments (4mm) is 2.25:1, clearly exceeding the 1.5:1 criterion established in the definition of coronary aneurysm.

Verification of exclusions:

No evidence of congenital aneurysm (adult patient, without history of congenital cardiac anomalies)
No active mucocutaneous lymph node syndrome or previously documented history of Kawasaki disease
Not a dissection (no layer separation or false lumen)
No coronary fistula (absence of abnormal communication)
No occlusion (patent vessel with preserved flow)

Code selected: BA81 - Coronary artery aneurysm

Complete justification: Code BA81 is appropriate because there is objective documentation of coronary dilatation that exceeds by more than 1.5 times the diameter of normal adjacent segments. The aneurysm is acquired, likely of atherosclerotic etiology considering the patient's risk factors and the presence of calcifications on the aneurysm walls. The condition was discovered during investigation of chest symptoms, although the aneurysm itself may not be the direct cause of the symptoms.

Applicable complementary codes:

Code for arterial hypertension (to document comorbidity)
Code for dyslipidemia (to document risk factor)
Code for mild coronary atherosclerotic disease (to document non-obstructive atherosclerosis in other segments)

Documented follow-up plan: Platelet aggregation inhibition, strict control of risk factors, image reevaluation in 6-12 months to monitor aneurysm evolution, consider anticoagulation if there is evidence of thrombi on future examinations.

7. Related Codes and Differentiation

Within the Same Category

BA82: Dissection of coronary artery

Coronary dissection is characterized by separation of the layers of the arterial wall, creating a false lumen where blood accumulates between the layers. This condition typically presents acutely, with severe chest pain and can cause immediate myocardial ischemia by compromising blood flow.

When to use BA82 vs. BA81: Use BA82 when there is imaging documentation of separation of arterial layers with false lumen. Use BA81 when there is arterial wall dilation without layer separation. The main difference is that in dissection there is rupture of the intima with blood penetration between the layers, whereas in aneurysm there is dilation of all layers while maintaining structural continuity.

BA83: Acquired fistula of coronary artery

Acquired coronary fistulas represent abnormal communications between coronary arteries and cardiac chambers, pulmonary artery, cardiac veins, or other structures. They may result from trauma, invasive procedures, infarction, or aneurysm rupture.

When to use BA83 vs. BA81: Use BA83 when there is documented abnormal communication between the coronary artery and another cardiovascular structure, with evidence of shunt or abnormal flow. Use BA81 when there is only aneurysmal dilation without abnormal communication. If an aneurysm ruptures and creates a fistula, both codes may be necessary, with the fistula being the acute complication.

BA84: Total chronic occlusion of coronary artery

This condition refers to complete obstruction of coronary flow for a prolonged period (usually defined as greater than three months), with development of collateral circulation. It represents the final stage of obstructive atherosclerotic disease.

When to use BA84 vs. BA81: Use BA84 when there is documented complete occlusion of the coronary artery with absence of antegrade flow in the affected segment. Use BA81 when there is aneurysmal dilation with patent lumen and preserved flow. In rare cases where a previous aneurysm undergoes complete thrombosis and chronic occlusion, coding may require temporal analysis: BA81 for the aneurysm and BA84 if it progresses to total chronic occlusion.

Differential Diagnoses

Coronary ectasia: Diffuse dilation that does not meet the criterion of 1.5 times the normal diameter. Represents a less significant alteration and generally does not require specific coding as aneurysm.

Normal anatomical variation: Some individuals have naturally larger caliber coronary vessels without pathological character. Differentiation requires careful evaluation of proportions and clinical context.

Post-stenotic dilation: Occurs after significant obstructions due to hemodynamic alterations. Does not constitute true aneurysm.

8. Differences with ICD-10

In the International Classification of Diseases, 10th Revision (ICD-10), coronary artery aneurysm was coded as I25.4 - Coronary artery aneurysm. This coding was included in the chapter on ischemic heart diseases, within the grouping of chronic ischemic heart disease.

The transition to code BA81 in ICD-11 represents a significant evolution in the classification of this condition. The main conceptual change is the recognition that coronary aneurysm is not necessarily an ischemic disease, but rather a structural alteration of the vascular wall that may have various etiologies.

ICD-11 offers greater specificity by establishing a clear quantitative criterion (dilation greater than 1.5 times the normal diameter), eliminating ambiguities in code application. In ICD-10, there was no precise definition, allowing variability in coding among different professionals and institutions.

Another important change is the clear separation between congenital and acquired aneurysms in ICD-11, with distinct codes for each situation. In ICD-10, this distinction was not as explicit, and could cause confusion in coding aneurysms in young patients or those with a history of Kawasaki disease.

The practical impact of these changes includes greater epidemiological precision, allowing more accurate studies on the prevalence and incidence of this condition. For reimbursement systems, more specific coding can facilitate the justification of complex diagnostic and therapeutic procedures. For clinical research, standardization improves comparability between different studies and populations.

9. Frequently Asked Questions

1. How is coronary artery aneurysm diagnosed?

Diagnosis is established through cardiovascular imaging studies. Invasive coronary angiography remains the gold standard, allowing direct visualization of the vascular lumen and precise diameter measurements. Coronary computed tomography angiography is an excellent non-invasive method, offering detailed three-dimensional images and allowing assessment of vascular walls. Cardiac magnetic resonance imaging can also be used, especially for longitudinal follow-up. Transthoracic echocardiography rarely visualizes coronary aneurysms, except when they are very large and close to the origin of the arteries.

2. Is treatment available in public health systems?

Treatment of coronary aneurysms is generally available in medical centers with cardiology and cardiovascular surgery services. Management ranges from clinical observation with medical therapy (antiplatelet agents or anticoagulants) to more complex interventions. Percutaneous procedures with covered stent implantation can be performed in equipped hemodynamics laboratories. Revascularization surgery with aneurysm exclusion requires a cardiovascular surgical center. Specific availability depends on the infrastructure of each health system and geographic region.

3. How long does treatment last?

Treatment of coronary aneurysm is typically long-term or permanent. Patients under conservative management require continuous cardiologic follow-up, generally with imaging re-evaluations every 6-12 months initially, which can be spaced to annually if there is stability. Antithrombotic therapy (antiplatelet or anticoagulant agents) is usually maintained indefinitely. Patients undergoing percutaneous or surgical intervention still require prolonged follow-up, as they may develop late complications or progression of atherosclerotic disease in other segments.

4. Can this code be used in medical certificates?

Yes, code BA81 can and should be used in official medical documentation when there is confirmed diagnosis of coronary artery aneurysm. In medical certificates, the inclusion of the ICD-11 code standardizes the information and facilitates processing by administrative systems. However, it is important to consider that the simple presence of coronary aneurysm does not necessarily imply work incapacity. The decision regarding work leave should be based on the presence of symptoms, complications, need for procedures, or specific restrictions related to the patient's professional activities.

5. Can coronary aneurysms regress spontaneously?

Spontaneous regression of coronary aneurysms is extremely rare in adults. In children with aneurysms secondary to Kawasaki disease, there may be vascular remodeling with reduction in aneurysm dimensions in the first years after the acute phase, especially in small and medium-sized aneurysms. However, giant aneurysms (greater than 8mm in children or 20mm in adults) rarely regress. In adults with atherosclerotic aneurysms, the natural history tends toward stability or slow progression, with no expectation of regression. Therefore, longitudinal follow-up is essential.

6. What is the risk of rupture of a coronary aneurysm?

The risk of rupture of coronary aneurysms is generally considered low but increases with aneurysm size. Giant aneurysms present higher risk. Unlike aortic aneurysms, where rupture is a well-established complication, in coronary aneurysms the main concern is thrombosis with distal embolization or vessel occlusion, causing myocardial infarction. Rupture with cardiac tamponade is rare but can occur, especially in inflammatory or infectious aneurysms. Individualized risk assessment considers size, morphology, etiology, and presence of symptoms.

7. Can patients with coronary aneurysm practice physical exercise?

Recommendations regarding physical activity should be individualized. Patients with small, asymptomatic aneurysms without complications can generally maintain regular physical activities, with possible restrictions on very high-intensity or competitive exercises. Patients with large, symptomatic aneurysms or with complications may require more significant restrictions. Functional assessment through ergometric testing or cardiopulmonary testing can assist in safe exercise prescription. Activities involving direct thoracic trauma (contact sports) may be contraindicated in very large aneurysms due to the theoretical risk of rupture.

8. Is permanent anticoagulation necessary?

The need for anticoagulation depends on specific characteristics of the aneurysm. Platelet antiagregation (aspirin) is generally recommended for all patients. Full anticoagulation is considered when there is evidence of intraluminal thrombi, very large aneurysms (especially giant), documented slow flow, or history of embolic events. The decision should balance the risk of thrombosis versus bleeding risk, considering individual patient characteristics. In some cases, dual antiplatelet therapy may be chosen instead of anticoagulation. Regular follow-up with imaging studies assists in the decision to maintain, modify, or discontinue anticoagulation.

Conclusion

Coronary artery aneurysm, coded as BA81 in ICD-11, represents an important cardiovascular condition that requires appropriate recognition, precise coding, and appropriate management. Understanding the diagnostic criteria, the clinical situations where the code should be applied, and pertinent exclusions is fundamental for healthcare professionals involved in the care of these patients. Appropriate documentation not only ensures administrative accuracy but mainly contributes to appropriate clinical follow-up and epidemiological research of this relatively uncommon yet clinically significant condition.

External References

This article was prepared based on reliable scientific sources:

🌍 WHO ICD-11 - Coronary artery aneurysm
🔬 PubMed Research on Coronary artery aneurysm
🌍 WHO Health Topics
📊 Clinical Evidence: Coronary artery aneurysm
📋 Ministry of Health - Brazil
📊 Cochrane Systematic Reviews

References verified on 2026-02-04

Coronary Artery Aneurysm

Compartilhar